eLetters

128 e-Letters

published between 2006 and 2009

  • Blue light and Stargardt disease
    Robert M. Hammer

    Dear Editor,

    I enjoyed reading Paskowitz et al.'s (1) important summary of evidence indicating that in some specific types of retinal degeneration, light deprivation may prove to be of protective value. In respect of Stargardt Disease, they cite evidence from animal models that light deprivation can prevent A2E accumulation in the RPE, thus preventing the degeneration. A worthwhile point to note is that the dest...

    Show More
  • Author's Response
    Anne E Fung

    Dear Editor:

    With great interest, we read the comments of Dr. Ziemssen and colleagues regarding our World View paper discussing the results of the international intravitreal bevacizumab safety survey[1]. Their letter will certainly accentuate the importance of this topic to the ophthalmic community; we would like to clarify several of the points raised.

    In our paper, we have fully acknowledged the pur...

    Show More
  • The international intravitreal bevacizumab safety survey
    Focke Ziemssen

    Dear Editor,

    We read with interest the article by Fung et al. assessing complications related to single or repeated intravitreal injections of bevacizumab. [1] We congratulate the authors on studying this innovative therapy via internet and greatly appreciate the effort to gather timely information about the potentially related adverse events. Using a product for an indication not in the approved labeling, the ph...

    Show More
  • Glaucoma screening and optometric services
    Reshma S Thampy

    Dear Editor,

    Stoutenbeek and Jansonius have demonstrated high rates of optometric consultations in the Netherlands as a basis for screening populations at risk of glaucoma .One of the aims of screening is understood to be the early detection of morbidity. We recently published a review[1] of all glaucoma patients registered blind at Manchester Royal Eye Hospital in 2003 and found that only 42% of these had their...

    Show More
  • Giant retinal tear associated with gas tamponade
    Sujith Vengayil*

    Dear Editor,

    We read with great interest the scientific report published in your journal by Zaidi AA et al(1) regarding their experience with pneumatic retinopexy. We express our willingness to share our experience with a unique complication mentioned by the authors. Giant retinal tear was observed in one patient in the study by the author, which required scleral buckle with vitrectomy.

    A 32-year-old m...

    Show More
  • Persistent localised subretinal fluid after scleral buckling with silicone oil tamponade
    Veerappan R Saravanan

    Dear Editor,

    We read with keen interest the article by Atmaca-Sonmez et al on "Persistent detachment of the fovea after non-buckling repair of rhegmatogenous retinal detachment".[1] As stated in the article the presence of persistent detachment of the fovea and localised delayed subretinal fluid absorption (DSRFA) has been noted quite frequently after scleral buckling and pneumatic retinopexy, after the advent of...

    Show More
  • Authors' response
    Neeru Gupta MD PhD

    Dear Editor,

    We thank Dr. John Sloper for his comments regarding this clinical pathological case of advanced human glaucoma, visual field loss, and central visual system degeneration. [1] Dr. Sloper states "Gupta et al. state that both magnocellular and parvocellular cells from the lateral geniculate nucleus of a patient with glaucoma are significantly smaller than those in three control subjects." We respectf...

    Show More
  • Patching treatment and bullying
    Konstandina Koklanis

    Dear Editor,

    We read with great interest the “Bullying and eye patching” commentary by Williams and co-workers in which they report on the psychosocial implications of early versus late treatment of amblyopia.[1] In their birth cohort study, they found that early detection (screening at the age of 3 years and 1 month) and subsequent early treatment of amblyopia resulted in fewer reports of bullying victimisatio...

    Show More
  • Visual pathway changes in glaucoma
    John J Sloper

    Dear Editor,

    Gupta et al. state that both magnocellular and parvocellular cells from the lateral geniculate nucleus (LGN) of a patient with glaucoma are significantly smaller than those in three control subjects. However it would appear that the authors have used the sample sizes and standard deviation of the cell samples from each individual to make comparisons between subjects. This is statistically invalid...

    Show More
  • Effect of topical NSAID on IOP reduction by latanoprost
    Ciro Costagliola

    Dear Editor,

    We read with great interest the article by Chiba and co-workers about the possible effect on intraocular pressure (IOP) induced by non-steroidal anti-inflammatory (NSAID) ophthalmic solution in patients affected by primary open angle glaucoma (POAG) or ocular hypertension (OH) and treated with latanoprost [1].

    In 2003, Kashiwagi and Tsukahara (two co-authors of the above-mentioned Chiba et al...

    Show More

Pages